English
Home > Products > CAS:58-22-0

China CAS:58-22-0 Manufacturer

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for CAS:58-22-0, We warmly welcome prospects, organization associations and mates from everywhere in the earth to get in touch with us and request cooperation for mutual benefits.
CAS:58-22-0, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Related Products

Hot Products

  • Dutasteride

    Dutasteride

    Dutasteride has EP, USP, CP, IP, JP specification. CEP and FDA available.

    CAS:164656-23-9

  • Methylprednisolone Hemisuccinate

    Methylprednisolone Hemisuccinate

    For Methylprednisolone Hemisuccinate, we have EP, USP and CP specification. DMF and WC available.

    CAS:2921-57-5

  • Nintedanib Esylate

    Nintedanib Esylate

    Nintedanib Esylate has in-house specification. DMF available.

    CAS:656247-18-6

  • Testosterone Cypionate

    Testosterone Cypionate

    Testosterone Cypionate has USP specification. TP available and DMF under filing.

    CAS:58-20-8

  • Mometasone Furoate

    Mometasone Furoate

    Mometasone furoate has CP、EP、USP specifications. DMF under filing.

    CAS:83919-23-7

  • Mifepristone Capsules

    Mifepristone Capsules

    Mifepristone Capsules Specifications：10mg*1
    Indications：Emergency Contraceptive
  • Related Blog
  • Reviews

  • 2021 API Exhibition Wuhan

    October 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • 2023 See us at DCAT Week, CPHI and API exhibition!

  • Welcome to CPhI Korea 2024

    CPhI Korea 2024 will be held at COEX, Seoul Hall A from August 27 to 29, our booth number is M27.

  • Are There Any Side Effects or Risks Associated with Levonorgestrel Capsules

    As a leading provider in women's reproductive health, we at Humanwell often receive questions from individuals considering emergency contraception. One of the most frequent and important queries we encounter is about the safety profile of Levonorgestrel Capsules.

  • Methylprednisolone Market Trends: Key Developments in Corticosteroid Drug Manufacturing

    This article looks at key manufacturing trends surrounding Methylprednisolone, including API quality control, specification management, regulatory support, formulation requirements, and the role of experienced steroid API manufacturers such as Humanwell.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept